期刊文献+

α-L-岩藻糖苷酶在原发性肝癌诊断中的应用 被引量:2

下载PDF
导出
摘要 目的 :探讨α L 岩藻糖苷酶活性增高与原发性肝癌的关系。方法 :对原发性肝癌组 31例及对照组进行α L 岩藻糖苷酶活性检测 ,比较原发性肝癌组与对照组之间α L 岩藻糖苷酶活性的差异。结果 :原发性肝癌组的α L 岩藻糖苷酶活性明显高于对照组 ,经统计学处理差异有显著性 (P <0 .0 1)。结论 :α L 岩藻糖苷酶活性增高能对原发性肝癌做出早期、准确的临床诊断。
作者 姜萍 尤涛
机构地区 西安军工医院
出处 《实用医技杂志》 2004年第09A期1720-1721,共2页 Journal of Practical Medical Techniques
  • 相关文献

二级参考文献18

  • 1王念跃,临床检验杂志,1995年,13卷,301页
  • 2Herrick JB.Benson RL. The present status of coronaryarterial disease.[J].Arch Pathol Lab Med,1926,2:876-916.
  • 3Paterson JC. Vascularization and hemorrhage of the intima of arterioscleroticcoronary arteries[J].Arch Pathol Lab Med,1936,22:313-324.
  • 4Paterson JC. Capillary rupture with intimal hemorrhage as a causative factors incoronary thrombus[J].Arch Pathol Lab Med,1938,25:474-487.
  • 5Erlich JC. Low incidence of coronary thrombosis in myocardial infarction[J].ArchPathol Lab Med,1964,78:432-444.
  • 6Spain DM,et al. The relationship of coronary thrombosis to coronary athrosclersisand ischemic heart disease[J].Am J Med Sci,1960,240:701-710.
  • 7Chaman I. Morphogenesis of occluding coronary artery thrombosis[J].Arch Pathol LabMed ,1965,80:256-261.
  • 8Rentrop KP. Development and pathophysiological basis of throbolytic therapy inacute myocardial infarction. Part Ⅰ1912-1977:the controversy over the pathogenetic roleof thrombus in acute myocardial infarction[J].J Interven Cardiol,1998,11:255-263.
  • 9Rentrop KP. Development and pathophysiological basis of thrombolytic threapy inacute myocardial infarction. Part Ⅱ 1977-1980:the pathogenetic role of thrombus isestablished by the Goettingen pilot studies of mechanical interventions and intracoronarythrombolysis in acute myocardial infarction[J].J Intern Cardiol,1998,11:265-285.
  • 10De Wood MA,et al. Prevalance of total coronary occlusion during the early hours oftransmural myocardial infacrtion[J].N Engl J Med,1980,303:897-902.

共引文献42

同被引文献20

  • 1庄辉,周乙华.积极防治艾滋病合并乙型肝炎和丙型肝炎病毒感染[J].中华预防医学杂志,2004,38(5):294-295. 被引量:4
  • 2张抗,万雄萍.血清中α-L-岩藻糖苷酶及其在肝癌诊断中的作用[J].临床检验杂志,1994,12(4):214-215. 被引量:18
  • 3刘建武.连续监测法测定血清 α-L-岩藻糖苷酶[J].临床检验杂志,1997,15(3):153-154. 被引量:16
  • 4Haydon GH,Hayes PC. Screening for hepatocellular carcinoma[J].European Journal of Gastroenterology and Hepatology,1996,(09):856-860.
  • 5Lopez JB. Recent developments in the first detection of hepatocellular carcinoma[J].Clinical Microbiology Reviews,2005,(03):65-79.
  • 6Amit S,Jorge AM. Screening for hepatocellular carcinoma[J].Gastroenterol Hepatol (N Y),2008,(03):201-208.
  • 7Lopez JB,Thambyrajah V,Balasegaram M. Appropriate cut-off levels for serum alpha-fetoprotein in hepatocellular carcinoma[J].Diag Oncol,1994,(02):287-291.
  • 8Marx GM,Boyce A,Goldstein D. Elevated alpha-foetoprotein and hepatic metastases-it's not always what it seems![J].Annals of Oncology,2002,(01):167-169.
  • 9Collier J,Sherman M. Screening for hepatocellular carcinoma[J].Hepatology,1998,(01):273-278.
  • 10Leray G,Deugnier Y,Jouanolle AM. Biochemical aspects of alpha-L-fucosidase in hepatocellular carcinoma[J].Hepatology,1989,(02):249-252.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部